-
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
-
ChemBase ID:
158418
-
Molecular Formular:
C20H32O5
-
Molecular Mass:
352.46508
-
Monoisotopic Mass:
352.22497412
-
SMILES and InChIs
SMILES:
CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C/CCCC(=O)O)O)O
Canonical SMILES:
CCCCC[C@@H](C=C[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C/CCCC(=O)O)O
InChI:
InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1
InChIKey:
XEYBRNLFEZDVAW-DODZYUBVSA-N
-
Cite this record
CBID:158418 http://www.chembase.cn/molecule-158418.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
|
|
|
IUPAC Traditional name
|
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
|
|
|
Synonyms
|
(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
|
Dinoprostone
|
PGE2
|
Prostaglandin E2
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
4.3033595
|
H Acceptors
|
5
|
H Donor
|
3
|
LogD (pH = 5.5)
|
2.0038702
|
LogD (pH = 7.4)
|
0.2647247
|
Log P
|
3.22527
|
Molar Refractivity
|
99.4351 cm3
|
Polarizability
|
38.188305 Å3
|
Polar Surface Area
|
94.83 Å2
|
Rotatable Bonds
|
12
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
82475
|
Other Notes Differential effect of PGE2 on transforming growth factor-β, and insulin-induced collagen formation in lung fibroblasts2 Biochem/physiol Actions Most biologically active prostaglandin. PGE2 induces cervical ripening and parturition; mediates bradykinin-induced vasodilation; regulates adenylyl cyclase. Tumor cells that over-express cyclooxygenase 2 display increased invasiveness, angiogenesis, and resistance to apoptosis that may be due to the PGE2-induced expression of angiogenic factors and stabilization of the anti-apoptotic protein, survivin.The effect of PGE2 on the immune system is mixed. It inhibits T cell activation in vitro, suggesting it is an immunosuppressant. However, in vivo, it appears to effect expansion of the Th17 subset and differentiation of the Th1 subset of T helper cells, marking it as an immunoactivator.1 |
PATENTS
PATENTS
PubChem Patent
Google Patent